FDA Approved: METRONIDAZOLE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved Baxter Healthcare Corporation's supplemental application for metronidazole under NDA 018657.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amoebiasis
• Anaerobic Bacterial Infection
• Bacterial Vaginosis
• Clostridioides Difficile Infection
• Gynecologic Infection
• Intraabdominal Infection
• Pelvic Inflammatory Disease
• Trichomoniasis

Drugs mentioned

• METRONIDAZOLE (Metronidazole)

Snippet

SUPPL AP for METRONIDAZOLE (METRONIDAZOLE)